Get started
SSS

SYNTHETICMR AB

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

SYNT chart


Full chart

SYNT upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪333.51 M‬ SEK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.14 SEK
Net income (FY)
‪10.01 M‬ SEK
Revenue (FY)
‪89.21 M‬ SEK
Shares float
‪18.55 M‬
Beta (1Y)
0.09

Employees


Employees (FY)
37
Change (1Y)
+8 +27.59%
Revenue / Employee (1Y)
‪237.98 K‬ SEK
Net income / Employee (1Y)
‪26.71 K‬ SEK

About SYNTHETICMR AB


Sector
Health Technology
Industry
Medical Specialties
CEO
Ulrik Harrysson
Website
syntheticmr.com
Headquarters
Linköping
Founded
2007
ISIN
SE0015987946
FIGI
BBG005F21BP4
SyntheticMR AB engages in the development and marketing of software solutions for magnetic resonance imaging. The firm offers products under the brand SyMRI. Its products include SyMRI NEURO and SyMRI Spine. The company was founded by Jan Bertus Marten Warntjes on February 16, 2007 and is headquartered in Linköping, Sweden.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

SYNT news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of SYNT is 7.70 SEK — it has increased by 3.25% in the past 24 hours. Watch SYNTHETICMR AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange SYNTHETICMR AB stocks are traded under the ticker SYNT.
SYNT stock has fallen by −31.17% compared to the previous week, the month change is a −31.45% fall, over the last year SYNTHETICMR AB has showed a −67.92% decrease.
We've gathered analysts' opinions on SYNTHETICMR AB future price: according to them, SYNT price has a max estimate of 18.00 SEK and a min estimate of 15.00 SEK. Watch SYNT chart and read a more detailed SYNTHETICMR AB stock forecast: see what analysts think of SYNTHETICMR AB and suggest that you do with its stocks.
SYNT reached its all-time high on Sep 6, 2021 with the price of 84.00 SEK, and its all-time low was 1.90 SEK and was reached on Oct 18, 2013. View more price dynamics on SYNT chart.
See other stocks reaching their highest and lowest prices.
SYNT stock is 7.53% volatile and has beta coefficient of 0.09. Track SYNTHETICMR AB stock price on the chart and check out the list of the most volatile stocks — is SYNTHETICMR AB there?
Today SYNTHETICMR AB has the market capitalization of ‪333.51 M‬, it has decreased by −31.33% over the last week.
Yes, you can track SYNTHETICMR AB financials in yearly and quarterly reports right on TradingView.
SYNTHETICMR AB is going to release the next earnings report on Feb 25, 2025. Keep track of upcoming events with our Earnings Calendar.
SYNT net income for the last quarter is ‪−6.87 M‬ SEK, while the quarter before that showed ‪−7.37 M‬ SEK of net income which accounts for 6.78% change. Track more SYNTHETICMR AB financial stats to get the full picture.
SYNTHETICMR AB dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has 37.00 employees. See our rating of the largest employees — is SYNTHETICMR AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SYNTHETICMR AB EBITDA is ‪4.97 M‬ SEK, and current EBITDA margin is 18.34%. See more stats in SYNTHETICMR AB financial statements.
Like other stocks, SYNT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYNTHETICMR AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SYNTHETICMR AB technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SYNTHETICMR AB stock shows the sell signal. See more of SYNTHETICMR AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.